Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoMed Pharmaceuticals Inc (NASDAQ:OMED)

12.05
Delayed Data
As of Sep 23
 -0.26 / -2.11%
Today’s Change
8.42
Today|||52-Week Range
23.98
-46.54%
Year-to-Date
No recent news for OncoMed Pharmaceuticals Inc.

Today’s Trading

Previous close12.31
Today’s open12.34
Day’s range12.04 - 12.56
Volume113,068
Average volume (3 months)201,471
Market cap$432.4M
Dividend yield--
Data as of 09/23/2016

Growth & Valuation

Earnings growth (last year)-68.05%
Earnings growth (this year)-18.13%
Earnings growth (next 5 years)--
Revenue growth (last year)-34.53%
P/E ratioNM
Price/Sales26.13
Price/Book102.20

Competitors

 Today’s
change
Today’s
% change
ADXSAdvaxis Inc-0.18-1.64%
DVAXDynavax Technologies...-0.21-1.81%
ARNAArena Pharmaceutical...-0.03-1.69%
PGNXProgenics Pharmaceut...-0.11-1.80%
Data as of 09/23/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.79
Annual revenue (last year)$25.9M
Annual profit (last year)-$85.4M
Net profit margin-329.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul J. Hastings
CFO, SVP-Corporate Development &
Finance
Sunil Patel
Corporate headquarters
Redwood City, California

Forecasts

Search for Jobs